Emergency Responder Health Monitoring and Surveillance, 6475 [2011-2527]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 24 / Friday, February 4, 2011 / Notices
during the pre-, during-, and postdeployment phases will also help to
identify which responders would
benefit from medical referral and
possible enrollment in a long-term
health surveillance program.
The document, entitled ‘‘Emergency
Responder Health Monitoring and
Surveillance,’’ can be viewed at:
https://www.cdc.gov/niosh/docket/
review/docket223/.
This guidance does not have the force
and effect of the law.
Public Comment Period: Comments
must be received by April 5, 2011.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–223]
Emergency Responder Health
Monitoring and Surveillance
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft publication
available for public comment.
AGENCY:
srobinson on DSKHWCL6B1PROD with NOTICES
VerDate Mar<15>2010
16:05 Feb 03, 2011
Jkt 223001
Written comments may be
submitted to the NIOSH Docket Office,
identified by Docket Number NIOSH–
223, by any of the following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
ADDRESSES:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following draft publication for public
comment. The document is entitled,
‘‘Emergency Responder Health
Monitoring and Surveillance.’’
The draft document and instructions
for submitting comments can be found
at: https://www.cdc.gov/niosh/docket/
review/docket223/.
The document proposes a new
framework for ensuring responder safety
and health by monitoring and
conducting surveillance of their health
and safety during the entire cycle of
emergency response, including the predeployment, deployment, and postdeployment phases of a response. The
proposed system is referred to as the
‘‘Emergency Responder Health
Monitoring and Surveillance (ERHMS)’’
system, which includes a guidance
section describing the principles of
ensuring optimal responder safety and
health, as well as a tools section to help
facilitate the execution of these
principles during an actual response.
The goals of this proposed system are
to ensure that only properly trained and
fit responders are deployed to a
response, that the health and safety of
all responders are appropriately
monitored during a response, and that a
systematic and comprehensive
evaluation be conducted to determine
the potential need for long term
surveillance of responders’ health after
their deployment has been completed.
This system will help to ensure that
hazardous occupational exposures and
signs and symptoms observed during an
emergency response are utilized to
mitigate adverse physical and
psychological outcomes and determine
whether protective measures are
sufficient to prevent or reduce harmful
exposures to workers. Data collected
SUMMARY:
All information received in response to
this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Room 111, Cincinnati, Ohio 45226.
A complete electronic docket
containing all comments submitted will
be available on the NIOSH Web page at
https://www.cdc.gov/niosh/docket, and
comments will be available in writing
by request. NIOSH includes all
comments received without change in
the docket, including any personal
information provided. All electronic
comments should be formatted as
Microsoft Word. Please make reference
to Docket Number NIOSH–223.
FOR FURTHER INFORMATION CONTACT:
´
Renee Funk, D.V.M., telephone (404)
498–1376, e-mail rjf8@cdc.gov, NIOSH,
MS–E20, 1600 Clifton Road NE.,
Atlanta, GA 30333.
Dated: January 28, 2011.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2011–2527 Filed 2–3–11; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
6475
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0603]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Animal Drug User
Fees and Fee Waivers and Reductions
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by March 7,
2011.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0540. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Johnny Vilela, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7651, e-mail:
Juanmanuel.vilela@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUMMARY:
Animal Drug User Fees and Fee
Waivers and Reductions—(OMB
Control Number 0910–0540)—Extension
Enacted on November 18, 2003, the
Animal Drug User Fee Act (ADUFA)
(Pub. L. 108–130) amended the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) and requires FDA to assess
and collect user fees for certain
applications, products, establishments,
and sponsors. It also requires the
Agency to grant a waiver from or a
reduction of those fees in certain
circumstances. Thus, to implement this
statutory provision of ADUFA, FDA
developed a guidance entitled
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 76, Number 24 (Friday, February 4, 2011)]
[Notices]
[Page 6475]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2527]
[[Page 6475]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-223]
Emergency Responder Health Monitoring and Surveillance
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of draft publication available for public comment.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the availability of the following draft publication for
public comment. The document is entitled, ``Emergency Responder Health
Monitoring and Surveillance.''
The draft document and instructions for submitting comments can be
found at: https://www.cdc.gov/niosh/docket/review/docket223/.
The document proposes a new framework for ensuring responder safety
and health by monitoring and conducting surveillance of their health
and safety during the entire cycle of emergency response, including the
pre-deployment, deployment, and post-deployment phases of a response.
The proposed system is referred to as the ``Emergency Responder Health
Monitoring and Surveillance (ERHMS)'' system, which includes a guidance
section describing the principles of ensuring optimal responder safety
and health, as well as a tools section to help facilitate the execution
of these principles during an actual response.
The goals of this proposed system are to ensure that only properly
trained and fit responders are deployed to a response, that the health
and safety of all responders are appropriately monitored during a
response, and that a systematic and comprehensive evaluation be
conducted to determine the potential need for long term surveillance of
responders' health after their deployment has been completed. This
system will help to ensure that hazardous occupational exposures and
signs and symptoms observed during an emergency response are utilized
to mitigate adverse physical and psychological outcomes and determine
whether protective measures are sufficient to prevent or reduce harmful
exposures to workers. Data collected during the pre-, during-, and
post-deployment phases will also help to identify which responders
would benefit from medical referral and possible enrollment in a long-
term health surveillance program.
The document, entitled ``Emergency Responder Health Monitoring and
Surveillance,'' can be viewed at: https://www.cdc.gov/niosh/docket/review/docket223/.
This guidance does not have the force and effect of the law.
Public Comment Period: Comments must be received by April 5, 2011.
ADDRESSES: Written comments may be submitted to the NIOSH Docket
Office, identified by Docket Number NIOSH-223, by any of the following
methods:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533-8285.
E-mail: nioshdocket@cdc.gov.
All information received in response to this notice will be available
for public examination and copying at the NIOSH Docket Office, 4676
Columbia Parkway, Room 111, Cincinnati, Ohio 45226.
A complete electronic docket containing all comments submitted will
be available on the NIOSH Web page at https://www.cdc.gov/niosh/docket,
and comments will be available in writing by request. NIOSH includes
all comments received without change in the docket, including any
personal information provided. All electronic comments should be
formatted as Microsoft Word. Please make reference to Docket Number
NIOSH-223.
FOR FURTHER INFORMATION CONTACT: Ren[eacute]e Funk, D.V.M., telephone
(404) 498-1376, e-mail rjf8@cdc.gov, NIOSH, MS-E20, 1600 Clifton Road
NE., Atlanta, GA 30333.
Dated: January 28, 2011.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2011-2527 Filed 2-3-11; 8:45 am]
BILLING CODE 4163-19-P
